Диссертация (1139931), страница 15
Текст из файла (страница 15)
Cardiol. – 2000. – Vol. 35. – P. 673–680.11743.A sensitive cardiac troponin T assay in stable coronary artery disease /T. Omland, J.A. de Lemos, M.S. Sabatine [et al.] // N. Engl. J. Med. –2009. – Vol. 361, № 26. – P. 2538-47.44.ACC/AHA 2002 guideline update for the management of patients withchronic stable angina--summary article: a report of the AmericanCollege of Cardiology/American Heart Association Task Force onpractice guidelines (Committee on the Management of Patients WithChronic Stable Angina) / R.J. Gibbons, J.
Abrams, K. Chatterjee [et al.]// J. Am. Coll. Cardiol. – 2003. – Vol. 41, № 1. – P. 159-68.45.ACCF/AHA 2011 expert consensus document on hypertension in theelderly: a report of the American College of Cardiology FoundationTask Force on Clinical Expert Consensus Documents developed incollaboration with the American Academy of Neurology, AmericanGeriatrics Society, American Society for Preventive Cardiology,American Society of Hypertension, American Society of Nephrology,Association of Black Cardiologists, and European Society ofHypertension / W.S. Aronow, J.L.
Fleg, C.J. Pepine [et al.] // J. Am.Soc. Hypertens. – 2011. – Vol. 5, № 4. – P. 259-352.46.Additive Value of Heart Rate Variability in Predicting ObstructiveCoronary Artery Disease Beyond Framingham Risk / H.R. Li, T.M. Lu,H.M. Cheng [et al.] // Circ. J. – 2016. – Vol. 80, № 2. – P. 494-501.47.All-cause mortality and cardiovascular events with nicorandil inpatients with IHD: systematic review and meta-analysis of the literature/ B.
Luo, P. Wu, T. Bu [et al.] // Int. J. Cardiol. – 2014. – Vol. 176, №3. – P. 661-9.48.Angina reassessed: pain or protector / D. Yellon, G.F. Baxter, M.S.Marber // Lancet. – 1996. – Vol. 347. – P. 1159-62.49.Antianginal efficacy of ranolazine when added to treatment withamlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina)118trial / P.H. Stone, N.A. Gratsiansky, A. Blokhin [et al.] // J. Am. Coll.Cardiol.
– 2006. – Vol. 48, № 3. – P. 56.50.Antiarrhythmic effect of ischemic preconditioning during low-flowischemia. The role of bradykinin and sarcolemmal versus mitochondrialATP-sensitive K(+) channels / S. Driamov, M. Bellahcene, A.
Ziegler[et al.] // Basic Res. Cardiol. – 2004. – Vol. 99, № 4. – P. 299-308.51.Arterial stiffness and cardiovascular events: the Framingham HeartStudy / G.F. Mitchell, S.J. Hwang, R.S Vasan [et al.] // Circulation. —2010. — Vol. 121. — P. 505–511.52.Association of arterial stiffness with coronary flow reserve inrevascularized coronary artery disease patients / V. Tritakis, S.Tzortzis, I. Ikonomidis [et al.] // World J. Cardiol.
– 2016. – Vol. 8, №2. – P. 231-9.53.Association of brachial-ankle pulse wave velocity with atherosclerosisand presence of coronary artery disease in older patients / C.M. Chung,Y.H. Tseng, Y.S. Lin [et al.] // Clin. Interv. Aging. – 2015. – № 10. –P. 1369-75.54.Atorvastatintreatmentimprovesendothelialfunctionthroughendothelial progenitor cells mobilization in ischemic heart failurepatients / E. Oikonomou, G. Siasos, M. Zaromitidou [et al.] //Atherosclerosis.
– 2015. – Vol. 238, № 2. – P. 159-64.55.Auch-Schwelk, W. Use of nitrates in coronary heart disease includingacute myocardial infarct / W. Auch-Schwelk // Herz. – 1996. – Vol. 21,Suppl. 1. – P. 31-4.56.Bradykinin is a mediator, but unlikely a trigger, of antiarrhythmiceffects of ischemic preconditioning / S.V. Driamov, M. Bellahcene, S.Butz [et al.] // J. Cardiovasc.
Electrophysiol. – 2007. – Vol. 18, № 1. –P. 93-9.57.Braunwald, E. Myocardial ischemia, infarction, and failure: an odyssey/ E. Braunwald // Cardioscience. – 1994. – Vol. 5, № 3. – P. 139-44.11958.Campeau, L. The Canadian Cardiovascular Society grading of anginapectoris revisited 30 years later / L.
Campeau // Can. J. Cardiol. – 2002.– Vol. 18, № 4. – P. 371-9.59.Candilio, L. Protection of organs other than the heart by remoteischemic conditioning / L. Candilio, A. Malik, D.J. Hausenloy // J.Cardiovasc. Med. (Hagerstown ). – 2013. – Vol. 14. – P. 193–205.60.Central but not brachial blood pressure predicts cardiovascular eventsin an unselected geriatric population: the ICAReDicomano Study / R.Pini, M.C.
Cavallini, V. Palmieri [et al.] // J. Am. Coll. Cardiol. —2008. — Vol. 51. — P. 2432–2439.61.Central pressure more strongly relates to vascular disease and outcomethan does brachial pressure: the Strong Heart Study / M.J. Roman, R.B.Devereux, J.R. Kizer [et al.] // Hypertension. — 2007. — Vol. 50. — P.197–203.62.Clevidence, M.W. The effects of ischemic preconditioning on aerobicandanaerobicvariablesassociatedwithsubmaximalcyclingperformance / M.W. Clevidence, R.E.
Mowery, M.R. Kushnick // Eur.J. Appl. Physiol. – 2012. – Vol. 112, № 10. – P. 3649-54.63.Cohen, M.V. Conscious rabbits become tolerant to multiple episodes ofischemic preconditioning / M.V. Cohen, X.M. Yang, J.M. Downey //Circ. Res. – 1994. – Vol. 74. – P. 998–1004.64.Correlation of heart rate variability with clinical and angiographicvariables and late mortality after coronary angiography / M.W. Rich,J.S. Saini, R.E. Kleiger [et al.] // Am. J. Cardiol. – 1988.
– Vol. 62. – P.714–17.65.Covic, A. Pulse wave velocity ratio: the new "gold standard" formeasuring arterial stiffness / A. Covic, D. Siriopol // Hypertension. –2015. – Vol. 65, № 2. – P. 289-90.66.Crisafulli, A. Ischemic preconditioning of the muscle improvesmaximal exercise performance but not maximal oxygen uptake in120humans / A. Crisafulli // J. Appl. Physiol.
– 2011. – Vol. 111, № 2. – P.530-6.67.Daily ischemic preconditioning provides sustained protection fromischemia-reperfusion induced endothelial dysfunction: a human study /M.C. Luca, A. Liuni, K. McLaughlin [et al.] // J. Am. Heart Assoc. –2013. – Vol. 2, № 1. – P. e000075.68.Dawber,T.R.TheFraminghamStudy.Theepidemiologyofatherosclerotic disease / T.R. Dawber. - Cambridge: M.A. HarvardUniversity Press, 1980.
– P. 45—56.69.Decreased heart rate variability and its association with increasedmortality after acute myocardial infarction / R.E. Kleiger, J.P. Miller,J.T. Bigger Jr. [et al.] // Am. J. Cardiol. – 1987. –Vol. 59. – P. 256–262.70.Decreased magnitude of heart rate spectral components in coronaryartery disease / J.
Hayano, Y. Sakakibara, M. Yamada [et al.] //Circulation. – 1990. – Vol. 81. – P. 1271–24.71.Does the relation of blood pressure to coronary heart disease riskchange with aging? The Framingham Heart Study / S.S. Franklin, M.G.Larson, S.A. Khan [et al.] // Circulation. – 2001. – Vol. 103. – P.
1245–1249.72.Duncan Ross. Insurers Now Using Noninvasive Central Blood Pressurein Medical Evaluations AtCor Medical Holdings Ltd: [Электронныйресурс].April07,201109:05ET.,2011.URL:http://www.atcormedical.com. (Дата обращения: 18.02.2014).73.Effect of ischemic preconditioning on repeated sprint ability in teamsport athletes / N. Gibson, B.
Mahony, C. Tracey [et al.] // J. Sports Sci.– 2015. – Vol. 33, № 11. – P. 1182-8.74.Effect of local and remote ischemic preconditioning on endothelialfunction in young people and healthy or hypertensive elderly people /121L. Moro, C. Pedone, A. Mondì [et al.] // Atherosclerosis. – 2011. – Vol.219, № 2. – P. 750-2.75.Effect of one-cycle remote ischemic preconditioning to reducemyocardial injury during percutaneous coronary intervention / T.A.Zografos, G.D. Katritsis, I. Tsiafoutis [et al.] // Am.
J. Cardiol. – 2014.– Vol. 113, № 12. – P. 2013-776.Effect of statins on endothelial function in patients with acute coronarysyndrome: a prospective study using adhesion molecules and flowmediated dilatation / I. Altun, F. Oz, S.C. Arkaya [et al.] // J.
Clin.Med. Res. – 2014. – Vol. 6, № 5. – P. 354-61.77.Effects of ischemic preconditioning on maximal constant-load cyclingperformance / R.S. Cruz, R.A. de Aguiar, T. Turnes [et al.] // J. Appl.Physiol. – 2015. - Vol. 119, № 9. – P. 961-967.78.Effects of pre- and postconditioning on arrhythmogenesis in the invivo rat model / T.M.
Kolettis, A.D. Vilaeti, D.G. Tsalikakis [et al.] // J.Cardiovasc. Pharmacol. Ther. – 2013. – Vol. 18, № 4. – P. 376-85.79.Electrocardiographic infarct size assessment after thrombolysis:insights from the Acute Myocardial Infarction STudyADenosine(AMISTAD) trial / A.
Barbagelata, M.F. Di Carli, R.M. Califf [et al.] //Am. Heart J. – 2005. – Vol. 150, № 4. – P. 659-65.80.Eurоpean Netwоrk fоr Nоn-invasive Investigation оf Large Arteries:Expert cоnsensus dоcument оn arterial stiffness: methodоlogical issuesand clinical applications / S. Laurent, J. Cockcroft, L. Van Bortel [etal.] // Eur. Heart J.
- 2006. – Vol. 27. – P. 2588–2605.81.Expert consensus dоcument оn arterial stiffness: methоdological issuesand clinical applications / S. Laurent, J. Cockcroft, L. Van Bortel [etal.] // Eur. Heart J. – 2006. – Vol. 27. – P. 2588—2605.82.Expert consensus document on the measurement of aortic stiffness indaily practice using carotid-femoral pulse wave velocity / L.M. Van122Bortel, S. Laurent, P. Boutouyrie [et al.] // J. Hypertens. – 2012. – Vol.30. – P. 445–448.83.Fisch, S. Antianginal drugs. Part III. Clinical use of nitroglycerin / S.Fisch // Am. Heart J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
